1. Home
  2. CCG vs CVM Comparison

CCG vs CVM Comparison

Compare CCG & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheche Group Inc.

CCG

Cheche Group Inc.

HOLD

Current Price

$15.96

Market Cap

30.8M

Sector

N/A

ML Signal

HOLD

Logo Cel-Sci Corporation

CVM

Cel-Sci Corporation

HOLD

Current Price

$1.49

Market Cap

30.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCG
CVM
Founded
2014
1983
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.8M
30.1M
IPO Year
2023
1996

Fundamental Metrics

Financial Performance
Metric
CCG
CVM
Price
$15.96
$1.49
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$350.00
N/A
AVG Volume (30 Days)
20.7K
134.4K
Earning Date
05-27-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$264,033.00
Revenue This Year
N/A
N/A
Revenue Next Year
$567.38
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
65.45
52 Week Low
$0.34
$0.89
52 Week High
$18.16
$10.83

Technical Indicators

Market Signals
Indicator
CCG
CVM
Relative Strength Index (RSI) 43.82 50.03
Support Level $0.65 $1.34
Resistance Level $16.17 $1.59
Average True Range (ATR) 1.66 0.10
MACD -0.71 -0.01
Stochastic Oscillator 17.95 42.35

Price Performance

Historical Comparison
CCG
CVM

About CCG Cheche Group Inc.

Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services, and other services in China. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.

About CVM Cel-Sci Corporation

CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.

Share on Social Networks: